schliessen

Filtern

 

Bibliotheken

1.

The problem with neoantigen prediction
by Anon

Nature biotechnology, 2017, Vol.35 (2), p.97-97

6.

Railroading at the FDA
by Anon

Nature biotechnology, 2016, Vol.34 (11), p.1078-1078

8.

Single-cell microbiology
by Anon

Nature biotechnology, 2016, Vol.34 (11), p.1077-1077

9.

The double edge of cancer immunotherapy
by Anon

Nature medicine, 2017, Vol.23 (2), p.137-137

10.

Railroading at the FDA
by Anon

Nature medicine, 2016, Vol.22 (11), p.1193-1193

11.

Take science off the stand
by Anon

Nature medicine, 2017, Vol.23 (3), p.265-265

12.

Recent patents in chimeric antigen receptors
by Anon

Nature biotechnology, 2017, Vol.35 (3), p.215-215

13.

The curse of uncertainty
by Anon

Nature medicine, 2017, Vol.23 (5), p.527-527

14.

Correction
by Anon

Nature medicine, 2017, Vol.23 (5), p.534-534

15.

Crystallizing sugar science
by Anon

Nature medicine, 2016, Vol.22 (12), p.1369-1369

16.

Science over speed
by Anon

Nature medicine, 2017, Vol.23 (4), p.397-397

17.

Correction
by Anon

Nature medicine, 2017, Vol.23 (4), p.404-404

18.

Mental health horizons
by Anon

Nature medicine, 2016, Vol.22 (11), p.1213-1213

19.

Trump's pick rallies biosimilar makers
by Anon

Nature biotechnology, 2017, Vol.35 (3), p.189-189

20.

Biogen pays Forward in Tecfidera dispute
by Anon

Nature biotechnology, 2017, Vol.35 (3), p.189-189

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 12.560 Hits